Platelet-to-lymphocyte ratio

There are 154 papers on platelet-to-lymphocyte ratio in aging research: 4 trials and 146 observational studies in people, 1 in animals, 3 reviews. The newest story, Nov 9, 2026: “Cancer survivors with obesity had more cardiovascular disease”.

Biomarker

154 papers study it15 more mention it46 findings

17 new papers in 30 daysSee all 169 papers on platelet-to-lymphocyte ratio

At a glance

Human observational studies link platelet-to-lymphocyte ratio with sarcopenia, frailty and osteoporosis, while a study finds no clear link with primary sarcopenia. Hip-fracture studies report mortality associations or no clear link. An observational study reports no clear improvement in frailty classification when the ratio is added to a core geriatric model.

46 findings in 42 papers from 2017 to 2026, 10 of them since April 2026

“platelet-to-lymphocyte ratio (PLR) and platelet-to-leukocyte ratio (PWR) demonstrated modest inverse associations (5-13% decreased risk).”
Unravelling the role of inflammatory markers in coronary artery disease risk via association, mediation and prediction analysesJournal of global health2026doi:10.7189/jogh.16.04060
  • Human trial4
  • Humans146
  • Animals1

Interventions

1

Atorvastatin

no changein humans1

1 study
  1. Atorvastatin showed no clear effect on platelet-to-lymphocyte ratio in humans (STEMI undergoing PPCI).

    “No significant inter-group difference was found in the 48-h PLR.”

    Human trialSTEMI undergoing PPCI48-h

    Differential effects of pre-procedural atorvastatin versus rosuvastatin on hematologic and inflammatory markers in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: A randomized controlled trial

    American heart journal plus : cardiology research and practice

More on Atorvastatin

Effects

7

Mortality

no changein humans3

3 studies
  1. Platelet-to-lymphocyte ratio was not clearly linked with mortality in humans (at initiation of hemodialysis).

    “No significant association was detected between NLR, PLR, and mortality.”

    Humansat initiation of hemodialysis

    Evaluation of the Effects of Glomerular Filtration Rate, Neutrophil-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio on Mortality at the Initiation of Hemodialysis

    Research SquarePreprint

  2. Platelet-to-lymphocyte ratio was not clearly linked with mortality in humans after hip fracture surgery.

    “NLR and PLR did not significantly predict mortality at any time point.”

    Humansafter hip fracture surgery1 yearn = 469

    Prognostic value of three inflammatory markers for mortality after hip fracture in the geriatric population

    Scientific reports

  3. Platelet-to-lymphocyte ratio was not clearly linked with mortality in humans (hip fracture).

    “The variable of PLR was not found valuable for early mortality.”

    Humanship fracturen = 335

    Standard and Newly Defined Prognostic Factors Affecting Early Mortality After Hip Fractures

    Cureus

Incremental frailty classification performance

no changein humans1

1 study
  1. Platelet-to-lymphocyte ratio was not clearly linked with incremental frailty classification performance in humans (Added to the core geriatric model).

    “the small increase with PLR had a bootstrap confidence interval that included zero.”

    HumansAdded to the core geriatric modeln = 284

    Comprehensive Geriatric Assessment Domains and Routine Inflammatory Indices in Relation to Clinical Frailty Scale-Defined Frailty: A Cross-Sectional Study in Hospital-Based Older Adults

    Healthcare (Basel, Switzerland)

Major depressive disorder

no changein humans1

1 study
  1. Platelet-to-lymphocyte ratio was not clearly linked with Major depressive disorder in humans.

    “whereas PLR and MHR were not independently associated after adjustment.”

    Humans

    Associations Between Major Depressive Disorder, Multimorbidity Burden, and Inflammatory Biomarkers (NLR, PLR, MLR, SII, and MHR) in a Primary Care Population

    Journal of clinical medicine

More on Major depressive disorder

Physical function

downin humans1OR 1.004

1 study
  1. Platelet-to-lymphocyte ratio is linked with worse physical function in humans (non-dialysis chronic kidney disease) (OR = 1.004, 95% CI: 1.001–1.006, P = 0.014).

    “PLR (OR = 1.004, 95% CI: 1.001–1.006, P = 0.014) were independently associated with physical function dependence”

    Humansnon-dialysis chronic kidney diseasen = 1,005

    The association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, red blood cell distribution width, and physical function in elderly non-dialysis patients with chronic kidney disease

    BMC geriatrics

Cataract

no changein humans1

1 study
  1. Platelet-to-lymphocyte ratio was not clearly linked with cataract in U.S. adults.

    “no such associations was identified between the PLR and cataracts.”

    Humansin U.S. adults

    Predictive role of the peripheral blood inflammation indices neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immunoinflammatory index (SII) for age-related cataract risk

    PloS one

More on Cataract

Handgrip strength

downin humans1

1 study
  1. Platelet-to-lymphocyte ratio is linked with lower handgrip strength in elderly diabetics (-11.3%, β = -0.12, p = 0.020).

    “while PLR by 11.3% (β = -0.12; t = -2.36; p = 0.020)”

    Humansin elderly diabeticsn = 138

    Predictive Models of Muscle Strength in Older People with Type 2 Diabetes Mellitus

    Clinical interventions in aging

Survival rate

downin humans1

1 study
  1. Platelet-to-lymphocyte ratio is linked with lower survival rate in maintenance hemodialysis patients.

    “Patients with high NLR and PLR levels showed a lower 3-year survival rate.”

    Humansin maintenance hemodialysis patients3 yearsn = 185

    Study on the Clinical Implications of NLR and PLR for Diagnosing Frailty in Maintenance Hemodialysis Patients and Their Correlations with Patient Prognosis

    Journal of healthcare engineering

Upstream

2

Primary sarcopenia

no changein humans1

1 study
  1. Primary sarcopenia was not clearly linked with platelet-to-lymphocyte ratio in humans (p=0.510).

    “No significant difference was found between the groups in terms of MPV/Plt, PDW/Plt, PLR”

    Humansn = 262

    Systemic inflammatory response index and monocyte-to-high density lipoprotein ratio- new biomarkers remarking the inflammation in primary sarcopenia: The SIMPS study

    Bratislavske lekarske listy

More on Primary sarcopenia

Frailty

upin humans1

1 study
  1. Frailty is linked with higher platelet-to-lymphocyte ratio in humans.

    “The NLR and PLR were both significantly higher in the GMC cohort comprised of older frailer patients with milder disease.”

    Humansin older frailer patients with milder COVID-19 compared to younger symptomatic general hospital patients

    Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio, are they markers of COVID-19 severity or old age and frailty? A comparison of two distinct cohorts

    Frontiers in medicine

Associations

25

Sarcopenia

upin humans4OR 1.455–2.36

4 studies
  1. Platelet-to-lymphocyte ratio is associated with sarcopenia in American and Chinese populations.

    “the roughly J-shaped curve was detected in the RCS plots for mean platelet volume and platelet-to-lymphocyte ratio with the risk of sarcopenia”

    Humansin American and Chinese populations

    Association of hematological parameters and inflammatory indices with sarcopenia in the United States and China: a cross-sectional study

    European journal of medical research

  2. Sarcopenia is associated with platelet-to-lymphocyte ratio in humans (critical limb ischemia) (127.16 vs 104.06, p = 0.010).

    “PLR was higher (127.16 vs 104.06, p = 0.010) among sarcopenic patients.”

    Humanscritical limb ischemian = 217

    Sarcopenia is a risk factor for major adverse cardiac events after surgical revascularization for critical limb ischemia

    Vascular

  3. Platelet-to-lymphocyte ratio is associated with sarcopenia in humans (cross-sectional analysis; highest vs lowest PLR group after adjustment for covariates) (OR 1.455 [1.177,1.799]).

    “neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and systemic immune-inflammation index (SII) were significantly associated with sarcopenia”

    Humanscross-sectional analysis; highest vs lowest PLR group after adjustment for covariatesn = 4,224

    The association between systemic inflammatory markers and sarcopenia: Results from the West China Health and Aging Trend Study (WCHAT)

    Archives of gerontology and geriatrics

  4. Platelet-to-lymphocyte ratio is associated with sarcopenia in humans (Highest serum PLR (≥155) versus lowest PLR (<90), adjusted for covariates) (OR 2.36, 95% CI 1.21–3.31; p < 0.01).

    “participants with highest serum PLR values (≥155) had 2.36 times greater risk of sarcopenia than those with lowest PLR values”

    HumansHighest serum PLR (≥155) versus lowest PLR (<90), adjusted for covariatesn = 3,671

    Higher Platelet-to-Lymphocyte Ratio Increased the Risk of Sarcopenia in the Community-Dwelling Older Adults

    Scientific reports

More on Sarcopenia

Osteoporosis

upin humans3OR 1.09–1.221

3 studies
  1. Platelet-to-lymphocyte ratio is associated with osteoporosis in humans (exploratory age-stratified analysis; association not observed in older groups) (OR 1.09 per 10-unit increase; P = 0.013).

    “PLR was associated with osteoporosis among women aged 50-64 years (OR 1.09 per 10-unit increase, P = 0.013), but not in older groups.”

    Humansexploratory age-stratified analysis; association not observed in older groupsfemales

    Age-platelet-to-lymphocyte ratio phenotypes and prevalent osteoporotic fracture in postmenopausal women: cross-cohort analysis with interpretable machine learning

    BMC endocrine disorders

  2. Platelet-to-lymphocyte ratio is linked with a higher risk of osteoporosis in humans (P for nonlinearity < .05).

    “Higher PLR showed a nonlinear positive association with osteoporosis risk (P for nonlinearity < .05)”

    Humans

    Interaction effects of testosterone and platelet-to-lymphocyte ratio on osteoporosis in U.S. adults: Insights from the NHANES 2011 to 2016 cohort

    Medicine

  3. Platelet-to-lymphocyte ratio is linked with a higher risk of osteoporosis in humans (OR = 1.221, CI = 1.001-1.488, P = 0.048).

    “Individuals in the highest tertiles of PLR had a 1.221-fold increase in osteoporosis prevalence compared to those in the lowest tertiles (OR = 1.221, CI = 1.001-1.488, P = 0.048).”

    Humans

    Systemic inflammation markers and the prevalence of osteoporosis and osteopenia: A NHANES cross-sectional study

    Journal of family medicine and primary care

More on Osteoporosis

Frailty

upin humans2downin humans1OR 2.54

3 studies
  1. Platelet-to-lymphocyte ratio is associated with frailty in humans (operable non-small-cell lung cancer).

    “Furthermore, both the NLR and PLR showed an inverse linear correlation with frailty severity”

    Humansoperable non-small-cell lung cancer

    The Association Between Inflammatory Scores and Frailty Severity: An Exploratory Retrospective Analysis in Non-Small-Cell Lung Cancer Surgical Patients

    Medical sciences (Basel, Switzerland)

  2. Platelet-to-lymphocyte ratio predicts frailty in maintenance hemodialysis patients (AUC 0.799).

    “The area under the receiver operating characteristic (ROC) curve of NLR and PLR in diagnosing frailty in MHD patients was 0.859 and 0.799, respectively.”

    Humansin maintenance hemodialysis patientsn = 185

    Study on the Clinical Implications of NLR and PLR for Diagnosing Frailty in Maintenance Hemodialysis Patients and Their Correlations with Patient Prognosis

    Journal of healthcare engineering

  3. Platelet-to-lymphocyte ratio is linked with a higher risk of frailty in humans (OR 2.54, 95% CI: 1.01-6.53).

    “logPLR (OR 2.54, 95% CI: 1.01-6.53)”

    Humans2-yearn = 1,822

    Association of immunity markers with the risk of incident frailty: the Rugao longitudinal aging study

    Immunity & ageing : I & A

Coronary artery disease

downin humans2

2 studies
  1. Platelet-to-lymphocyte ratio is associated with coronary artery disease in humans (Free of coronary artery disease at baseline) (5–13% decreased risk across PLR and PWR).

    “platelet-to-lymphocyte ratio (PLR) and platelet-to-leukocyte ratio (PWR) demonstrated modest inverse associations (5-13% decreased risk).”

    HumansFree of coronary artery disease at baselinen = 475,134

    Unravelling the role of inflammatory markers in coronary artery disease risk via association, mediation and prediction analyses

    Journal of global health

  2. Platelet-to-lymphocyte ratio is linked with a lower risk of coronary artery disease in humans.

    “we found that LMR, PLR, and SII all exhibited negatively significant correlation with CHD in the male group”

    Humansmales

    Associations of Inflammatory Markers and Coronary Heart Disease in Different Gender Groups in Cohort NHANES 2003-2018

    Cardiology research and practice

More on Coronary artery disease

Mortality

upin humans1downin humans1HR 1.39

2 studies
  1. Platelet-to-lymphocyte ratio is linked with a higher risk of mortality in humans (primary lung cancer, first chemotherapy course) (HR = 1.39, 95% CI = 1.17-1.64, P < 0.001).

    “or a PLR ≥ 125.11 (HR = 1.39, 95% CI = 1.17-1.64, P < 0.001) compared to those with values below these thresholds.”

    Humansprimary lung cancer, first chemotherapy coursen = 926

    Evaluation of the utility of different laboratory test-related sarcopenia indices as predictors of lung cancer mortality

    BMC geriatrics

  2. Platelet-to-lymphocyte ratio is associated with mortality in humans (critically ill).

    “while a higher platelet-to-lymphocyte ratio (PLR) was inversely related to mortality.”

    Humanscritically ill

    Host Response in Critically Ill Patients Aged 65 Years or Older: A Prospective Study

    Clinical interventions in aging

Incident atrial fibrillation

no changein humans1HR 1.03

1 study
  1. Platelet-to-lymphocyte ratio is associated with incident atrial fibrillation in humans (type 2 diabetes mellitus; covariate-adjusted Model 3) (HR 1.030, 95% CI 0.993–1.068; P=0.112).

    “The PLR association was not statistically significant (1.030; 0.993–1.068; P=0.112).”

    Humanstype 2 diabetes mellitus; covariate-adjusted Model 3per 1-SD increasen = 46,924

    Metabolic,Atherogenic,andInflammatoryIndicesandIncidentAtrialFibrillationinAdultsWith Type 2 Diabetes:A LargeLongitudinal CohortStudy

    Frontiers in endocrinology

More on Incident atrial fibrillation

High-grade cervical lesions

upin humans1

1 study
  1. Platelet-to-lymphocyte ratio predicts high-grade cervical lesions in humans (Women undergoing cervical cancer screening) (AUC 0.741).

    “while platelet-to-lymphocyte ratio showed lower specificity (area under the curve=0.741).”

    HumansWomen undergoing cervical cancer screeningfemalesn = 2,758

    Retrospective study of inflammatory markers in high-grade cervical lesions

    Revista da Associacao Medica Brasileira (1992)

More on High-grade cervical lesions

Cardiovascular mortality

upin humans1HR 1.13

1 study
  1. Platelet-to-lymphocyte ratio predicts cardiovascular mortality in humans (HR 1.13 (95% CI 1.04-1.22)).

    “and 1.13 (1.04-1.22) for PLR”

    Humans11.4 yearsn = 15,141

    Limited incremental value of three complete-blood-count inflammatory indices for cardiovascular mortality: a development and external validation study in 30,533 US adults

    medRxivPreprint

Chronic kidney disease

downin humans1

1 study
  1. Platelet-to-lymphocyte ratio is linked with a lower risk of chronic kidney disease in humans (obesity) (aOR 0.70, 95% CI 0.53-0.92).

    “whereas higher PLR was associated with reduced odds (aOR 0.70, 95% CI 0.53-0.92).”

    Humansobesity

    Association of immune-inflammatory markers with chronic kidney disease in older adults with obesity: a large-scale cross-sectional study

    Renal failure

More on Chronic kidney disease

Hippocampal volume fraction

downin humans1

1 study
  1. Platelet-to-lymphocyte ratio is associated with hippocampal volume fraction in humans (longitudinally).

    “Longitudinally, higher baseline PLR and SII were associated with faster HVF decline”

    Humanslongitudinallybrainn = 320

    Associations of peripheral inflammation with hippocampal atrophy in Alzheimer's disease

    Progress in neuro-psychopharmacology & biological psychiatry

More on Hippocampal volume fraction

All 25

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    A human preprint links platelet-to-lymphocyte ratio to cardiovascular mortality, whereas another reports no mortality association at hemodialysis initiation. A cervical screening study reports prediction of high-grade cervical lesions in women. Separate human studies link it to hippocampal volume fraction longitudinally and lower chronic kidney disease risk in obesity.

  2. Summary written from the findings.

Latest

Dec 2025: 5Jan 2026: 10Feb 2026: 13Mar 2026: 7Apr 2026: 4May 2026: 1Jun 2026: 5Jul 2026: 3Aug 2026: 8Sep 2026: 9Oct 2026: 13Nov 2026: 684 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Cancer survivors with obesity had more cardiovascular disease

Cardiovascular conditions affected 28.2% of cancer survivors with obesity, versus 15.6% of adults with obesity alone, despite lower levels of an inflammation marker.Cardiovascular conditions affected 28.2% of cancer survivors with obesity, versus 15.6% of adults with obesity alone, despite lower levels of an inflammation marker.

Cross-sectional · 325 peopleMechanisms

See all 169 papers on platelet-to-lymphocyte ratio